Global mRNA Vaccines for Infectious Diseases Market Insights, Forecast to 2028 - Market Study Report

Global mRNA Vaccines for Infectious Diseases Market Insights, Forecast to 2028

Report Format: PDF | Report ID: 4995278 | Published Date: April 18, 2022

Choose License
mRNA Vaccines for Infectious Diseases market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global mRNA Vaccines for Infectious Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
    Infectious Disease Vaccines
    Cancer Vaccines
Segment by Application
    Infectious Disease
    Cancer
By Company
    Moderna Therapeutics
    CureVac
    Translate Bio
    BioNTech
    Sangamo Therapeutics
    Argos Therapeutics
    In-Cell-Art
    eTheRNA
    Ethris
    Tiba Biotechnology
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Infectious Disease Vaccines
        1.2.3 Cancer Vaccines
    1.3 Market by Application
        1.3.1 Global mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Infectious Disease
        1.3.3 Cancer
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global mRNA Vaccines for Infectious Diseases Market Perspective (2017-2028)
    2.2 mRNA Vaccines for Infectious Diseases Growth Trends by Region
        2.2.1 mRNA Vaccines for Infectious Diseases Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 mRNA Vaccines for Infectious Diseases Historic Market Size by Region (2017-2022)
        2.2.3 mRNA Vaccines for Infectious Diseases Forecasted Market Size by Region (2023-2028)
    2.3 mRNA Vaccines for Infectious Diseases Market Dynamics
        2.3.1 mRNA Vaccines for Infectious Diseases Industry Trends
        2.3.2 mRNA Vaccines for Infectious Diseases Market Drivers
        2.3.3 mRNA Vaccines for Infectious Diseases Market Challenges
        2.3.4 mRNA Vaccines for Infectious Diseases Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top mRNA Vaccines for Infectious Diseases Players by Revenue
        3.1.1 Global Top mRNA Vaccines for Infectious Diseases Players by Revenue (2017-2022)
        3.1.2 Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Players (2017-2022)
    3.2 Global mRNA Vaccines for Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by mRNA Vaccines for Infectious Diseases Revenue
    3.4 Global mRNA Vaccines for Infectious Diseases Market Concentration Ratio
        3.4.1 Global mRNA Vaccines for Infectious Diseases Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by mRNA Vaccines for Infectious Diseases Revenue in 2021
    3.5 mRNA Vaccines for Infectious Diseases Key Players Head office and Area Served
    3.6 Key Players mRNA Vaccines for Infectious Diseases Product Solution and Service
    3.7 Date of Enter into mRNA Vaccines for Infectious Diseases Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Vaccines for Infectious Diseases Breakdown Data by Type
    4.1 Global mRNA Vaccines for Infectious Diseases Historic Market Size by Type (2017-2022)
    4.2 Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Type (2023-2028)
5 mRNA Vaccines for Infectious Diseases Breakdown Data by Application
    5.1 Global mRNA Vaccines for Infectious Diseases Historic Market Size by Application (2017-2022)
    5.2 Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America mRNA Vaccines for Infectious Diseases Market Size (2017-2028)
    6.2 North America mRNA Vaccines for Infectious Diseases Market Size by Type
        6.2.1 North America mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022)
        6.2.2 North America mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028)
        6.2.3 North America mRNA Vaccines for Infectious Diseases Market Share by Type (2017-2028)
    6.3 North America mRNA Vaccines for Infectious Diseases Market Size by Application
        6.3.1 North America mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022)
        6.3.2 North America mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028)
        6.3.3 North America mRNA Vaccines for Infectious Diseases Market Share by Application (2017-2028)
    6.4 North America mRNA Vaccines for Infectious Diseases Market Size by Country
        6.4.1 North America mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022)
        6.4.2 North America mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe mRNA Vaccines for Infectious Diseases Market Size (2017-2028)
    7.2 Europe mRNA Vaccines for Infectious Diseases Market Size by Type
        7.2.1 Europe mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022)
        7.2.2 Europe mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028)
        7.2.3 Europe mRNA Vaccines for Infectious Diseases Market Share by Type (2017-2028)
    7.3 Europe mRNA Vaccines for Infectious Diseases Market Size by Application
        7.3.1 Europe mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022)
        7.3.2 Europe mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028)
        7.3.3 Europe mRNA Vaccines for Infectious Diseases Market Share by Application (2017-2028)
    7.4 Europe mRNA Vaccines for Infectious Diseases Market Size by Country
        7.4.1 Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022)
        7.4.2 Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size (2017-2028)
    8.2 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Type
        8.2.1 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Share by Type (2017-2028)
    8.3 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Application
        8.3.1 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Share by Application (2017-2028)
    8.4 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Region
        8.4.1 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America mRNA Vaccines for Infectious Diseases Market Size (2017-2028)
    9.2 Latin America mRNA Vaccines for Infectious Diseases Market Size by Type
        9.2.1 Latin America mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022)
        9.2.2 Latin America mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028)
        9.2.3 Latin America mRNA Vaccines for Infectious Diseases Market Share by Type (2017-2028)
    9.3 Latin America mRNA Vaccines for Infectious Diseases Market Size by Application
        9.3.1 Latin America mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022)
        9.3.2 Latin America mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028)
        9.3.3 Latin America mRNA Vaccines for Infectious Diseases Market Share by Application (2017-2028)
    9.4 Latin America mRNA Vaccines for Infectious Diseases Market Size by Country
        9.4.1 Latin America mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022)
        9.4.2 Latin America mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size (2017-2028)
    10.2 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Type
        10.2.1 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Share by Type (2017-2028)
    10.3 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Application
        10.3.1 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Share by Application (2017-2028)
    10.4 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Country
        10.4.1 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Moderna Therapeutics
        11.1.1 Moderna Therapeutics Company Details
        11.1.2 Moderna Therapeutics Business Overview
        11.1.3 Moderna Therapeutics mRNA Vaccines for Infectious Diseases Introduction
        11.1.4 Moderna Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
        11.1.5 Moderna Therapeutics Recent Developments
    11.2 CureVac
        11.2.1 CureVac Company Details
        11.2.2 CureVac Business Overview
        11.2.3 CureVac mRNA Vaccines for Infectious Diseases Introduction
        11.2.4 CureVac Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
        11.2.5 CureVac Recent Developments
    11.3 Translate Bio
        11.3.1 Translate Bio Company Details
        11.3.2 Translate Bio Business Overview
        11.3.3 Translate Bio mRNA Vaccines for Infectious Diseases Introduction
        11.3.4 Translate Bio Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
        11.3.5 Translate Bio Recent Developments
    11.4 BioNTech
        11.4.1 BioNTech Company Details
        11.4.2 BioNTech Business Overview
        11.4.3 BioNTech mRNA Vaccines for Infectious Diseases Introduction
        11.4.4 BioNTech Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
        11.4.5 BioNTech Recent Developments
    11.5 Sangamo Therapeutics
        11.5.1 Sangamo Therapeutics Company Details
        11.5.2 Sangamo Therapeutics Business Overview
        11.5.3 Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Introduction
        11.5.4 Sangamo Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
        11.5.5 Sangamo Therapeutics Recent Developments
    11.6 Argos Therapeutics
        11.6.1 Argos Therapeutics Company Details
        11.6.2 Argos Therapeutics Business Overview
        11.6.3 Argos Therapeutics mRNA Vaccines for Infectious Diseases Introduction
        11.6.4 Argos Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
        11.6.5 Argos Therapeutics Recent Developments
    11.7 In-Cell-Art
        11.7.1 In-Cell-Art Company Details
        11.7.2 In-Cell-Art Business Overview
        11.7.3 In-Cell-Art mRNA Vaccines for Infectious Diseases Introduction
        11.7.4 In-Cell-Art Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
        11.7.5 In-Cell-Art Recent Developments
    11.8 eTheRNA
        11.8.1 eTheRNA Company Details
        11.8.2 eTheRNA Business Overview
        11.8.3 eTheRNA mRNA Vaccines for Infectious Diseases Introduction
        11.8.4 eTheRNA Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
        11.8.5 eTheRNA Recent Developments
    11.9 Ethris
        11.9.1 Ethris Company Details
        11.9.2 Ethris Business Overview
        11.9.3 Ethris mRNA Vaccines for Infectious Diseases Introduction
        11.9.4 Ethris Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
        11.9.5 Ethris Recent Developments
    11.10 Tiba Biotechnology
        11.10.1 Tiba Biotechnology Company Details
        11.10.2 Tiba Biotechnology Business Overview
        11.10.3 Tiba Biotechnology mRNA Vaccines for Infectious Diseases Introduction
        11.10.4 Tiba Biotechnology Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022)
        11.10.5 Tiba Biotechnology Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables Table 1. Global mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Infectious Disease Vaccines Table 3. Key Players of Cancer Vaccines Table 4. Global mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global mRNA Vaccines for Infectious Diseases Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global mRNA Vaccines for Infectious Diseases Market Size by Region (2017-2022) & (US$ Million) Table 7. Global mRNA Vaccines for Infectious Diseases Market Share by Region (2017-2022) Table 8. Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global mRNA Vaccines for Infectious Diseases Market Share by Region (2023-2028) Table 10. mRNA Vaccines for Infectious Diseases Market Trends Table 11. mRNA Vaccines for Infectious Diseases Market Drivers Table 12. mRNA Vaccines for Infectious Diseases Market Challenges Table 13. mRNA Vaccines for Infectious Diseases Market Restraints Table 14. Global mRNA Vaccines for Infectious Diseases Revenue by Players (2017-2022) & (US$ Million) Table 15. Global mRNA Vaccines for Infectious Diseases Revenue Share by Players (2017-2022) Table 16. Global Top mRNA Vaccines for Infectious Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines for Infectious Diseases as of 2021) Table 17. Ranking of Global Top mRNA Vaccines for Infectious Diseases Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by mRNA Vaccines for Infectious Diseases Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players mRNA Vaccines for Infectious Diseases Product Solution and Service Table 21. Date of Enter into mRNA Vaccines for Infectious Diseases Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022) & (US$ Million) Table 24. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Type (2017-2022) Table 25. Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Type (2023-2028) Table 27. Global mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022) & (US$ Million) Table 28. Global mRNA Vaccines for Infectious Diseases Revenue Share by Application (2017-2022) Table 29. Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global mRNA Vaccines for Infectious Diseases Revenue Share by Application (2023-2028) Table 31. North America mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022) & (US$ Million) Table 32. North America mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028) & (US$ Million) Table 33. North America mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022) & (US$ Million) Table 34. North America mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028) & (US$ Million) Table 35. North America mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022) & (US$ Million) Table 36. North America mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific mRNA Vaccines for Infectious Diseases Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific mRNA Vaccines for Infectious Diseases Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size by Country (2023-2028) & (US$ Million) Table 61. Moderna Therapeutics Company Details Table 62. Moderna Therapeutics Business Overview Table 63. Moderna Therapeutics mRNA Vaccines for Infectious Diseases Product Table 64. Moderna Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million) Table 65. Moderna Therapeutics Recent Developments Table 66. CureVac Company Details Table 67. CureVac Business Overview Table 68. CureVac mRNA Vaccines for Infectious Diseases Product Table 69. CureVac Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million) Table 70. CureVac Recent Developments Table 71. Translate Bio Company Details Table 72. Translate Bio Business Overview Table 73. Translate Bio mRNA Vaccines for Infectious Diseases Product Table 74. Translate Bio Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million) Table 75. Translate Bio Recent Developments Table 76. BioNTech Company Details Table 77. BioNTech Business Overview Table 78. BioNTech mRNA Vaccines for Infectious Diseases Product Table 79. BioNTech Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million) Table 80. BioNTech Recent Developments Table 81. Sangamo Therapeutics Company Details Table 82. Sangamo Therapeutics Business Overview Table 83. Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Product Table 84. Sangamo Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million) Table 85. Sangamo Therapeutics Recent Developments Table 86. Argos Therapeutics Company Details Table 87. Argos Therapeutics Business Overview Table 88. Argos Therapeutics mRNA Vaccines for Infectious Diseases Product Table 89. Argos Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million) Table 90. Argos Therapeutics Recent Developments Table 91. In-Cell-Art Company Details Table 92. In-Cell-Art Business Overview Table 93. In-Cell-Art mRNA Vaccines for Infectious Diseases Product Table 94. In-Cell-Art Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million) Table 95. In-Cell-Art Recent Developments Table 96. eTheRNA Company Details Table 97. eTheRNA Business Overview Table 98. eTheRNA mRNA Vaccines for Infectious Diseases Product Table 99. eTheRNA Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million) Table 100. eTheRNA Recent Developments Table 101. Ethris Company Details Table 102. Ethris Business Overview Table 103. Ethris mRNA Vaccines for Infectious Diseases Product Table 104. Ethris Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million) Table 105. Ethris Recent Developments Table 106. Tiba Biotechnology Company Details Table 107. Tiba Biotechnology Business Overview Table 108. Tiba Biotechnology mRNA Vaccines for Infectious Diseases Product Table 109. Tiba Biotechnology Revenue in mRNA Vaccines for Infectious Diseases Business (2017-2022) & (US$ Million) Table 110. Tiba Biotechnology Recent Developments Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Global mRNA Vaccines for Infectious Diseases Market Share by Type: 2021 VS 2028 Figure 2. Infectious Disease Vaccines Features Figure 3. Cancer Vaccines Features Figure 4. Global mRNA Vaccines for Infectious Diseases Market Share by Application: 2021 VS 2028 Figure 5. Infectious Disease Case Studies Figure 6. Cancer Case Studies Figure 7. mRNA Vaccines for Infectious Diseases Report Years Considered Figure 8. Global mRNA Vaccines for Infectious Diseases Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 9. Global mRNA Vaccines for Infectious Diseases Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global mRNA Vaccines for Infectious Diseases Market Share by Region: 2021 VS 2028 Figure 11. Global mRNA Vaccines for Infectious Diseases Market Share by Players in 2021 Figure 12. Global Top mRNA Vaccines for Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines for Infectious Diseases as of 2021) Figure 13. The Top 10 and 5 Players Market Share by mRNA Vaccines for Infectious Diseases Revenue in 2021 Figure 14. North America mRNA Vaccines for Infectious Diseases Market Size YoY (2017-2028) & (US$ Million) Figure 15. North America mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2017-2028) Figure 16. North America mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2017-2028) Figure 17. North America mRNA Vaccines for Infectious Diseases Market Size Share by Country (2017-2028) Figure 18. United States mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe mRNA Vaccines for Infectious Diseases Market Size YoY (2017-2028) & (US$ Million) Figure 21. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2017-2028) Figure 22. Europe mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2017-2028) Figure 23. Europe mRNA Vaccines for Infectious Diseases Market Size Share by Country (2017-2028) Figure 24. Germany mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size YoY (2017-2028) & (US$ Million) Figure 31. Asia Pacific mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2017-2028) Figure 32. Asia Pacific mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2017-2028) Figure 33. Asia Pacific mRNA Vaccines for Infectious Diseases Market Size Share by Region (2017-2028) Figure 34. China mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Japan mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. South Korea mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Southeast Asia mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. India mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Australia mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 40. Latin America mRNA Vaccines for Infectious Diseases Market Size YoY (2017-2028) & (US$ Million) Figure 41. Latin America mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2017-2028) Figure 42. Latin America mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2017-2028) Figure 43. Latin America mRNA Vaccines for Infectious Diseases Market Size Share by Country (2017-2028) Figure 44. Mexico mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Brazil mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size YoY (2017-2028) & (US$ Million) Figure 47. Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Type (2017-2028) Figure 48. Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size Market Share by Application (2017-2028) Figure 49. Middle East and Africa mRNA Vaccines for Infectious Diseases Market Size Share by Country (2017-2028) Figure 50. Turkey mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Saudi Arabia mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. UAE mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Moderna Therapeutics Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022) Figure 54. CureVac Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022) Figure 55. Translate Bio Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022) Figure 56. BioNTech Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022) Figure 57. Sangamo Therapeutics Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022) Figure 58. Argos Therapeutics Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022) Figure 59. In-Cell-Art Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022) Figure 60. eTheRNA Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022) Figure 61. Ethris Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022) Figure 62. Tiba Biotechnology Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2017-2022) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research

Budget constraint? Get in touch to get special pricing offers


Request For Discount

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support

Can't find what you're looking for about this report?

Submit Query

Go to contact form

Phone Number

1-302-273-0910
Chat with us